Global Viral Inactivation Market Worth USD 573.0 Million by 2021 - Increase in Biopharmaceutical Production Globally - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Viral Inactivation Market by Product - Global Forecast to 2021" report to their offering.

The global viral inactivation market is valued at USD 320.5 Million in 2016 and is expected to grow at a CAGR of 12.3%, to reach USD 573.0 Million by 2021. Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.

As the disease burden in the world is increasing the demand for the medicines is increasing hence the production of biologicals, injectables etc., is on a rise. Also, many of pharmaceutical and biotechnology firms are gearing to cater to the growing demands of medicines. This aids to the growth of market.

Owing to the rise in the number of biotechnology companies, biopharmaceutical production has increased globally. Viral inactivation is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the viral inactivation market.

Target Audience for this Report:

  • Viral inactivation product manufacturers and vendors
  • Research associations related to pharmaceutical and biotechnological research
  • Contract research organizations (CROs)
  • Various research and consulting firms
  • Healthcare institutions
  • Research institutes
  • Distributors of viral inactivation equipment

Companies Mentioned:

  • Charles River Laboratories International, Inc.
  • Clean Cells Inc.
  • Danaher Corporation
  • Merck KGAA
  • Parker Hannifin Corporation
  • Rad Source Technologies, Inc.
  • SGS SA
  • Sartorius AG
  • Texcell, Inc.
  • Viral Inactivated Plasma Systems SA
  • Wuxi Pharmatech (Cayman) Inc.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Viral Inactivation Market, By Method

7 Viral Inactivation Market, By Product

8 Viral Inactivation Market, By Application

9 Viral Inactivation Market, By End User

10 Viral Inactivation Market, By Geography

11 Competitive Landscape

12 Company Profiles

For more information visit http://www.researchandmarkets.com/research/jh6qn2/viral

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716